Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phosphoinositide 3-kinase (PI3K) pathway is a critical intracellular signaling cascade that regulates diverse cellular processes, including cell growth, proliferation, survival, metabolism, and angiogenesis. It is activated by various extracellular signals such as growth factors, cytokines, and hormones. Dysregulation of the PI3K pathway is frequently observed in human cancers, making it an attractive target for cancer therapy development.
Small molecule inhibitors targeting specific PI3K isoforms or downstream effectors like AKT/mTORC2
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphoinositide 3-kinase Pathway (PI3K pathway).